A key milestone achieved for Toronto Med device company Profound Medical as first patient is treated in TACT Pivotal Clinical Trial.
Profound Medical Corp. Announces First Patient Treated in TACT Pivotal Clinical Trial at Vanderbilt University Medical Center
TORONTO, Sept. 22, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSXV:PRN) ("Profound" or the "Company") a medical device company focused on prostate care, today announced that the first patient has been treated in the TACT Pivotal Clinical Trial at Vanderbilt University Medical Center in Nashville, TN.
Join in on the conversation with Zayna Khayat when you subscribe to Toronto Health.